Elekta AB (EKTAY)
7.365
+0.21
(+2.94%)
USD |
OTCM |
May 10, 15:58
Elekta Revenue (TTM): 1.723B for Jan. 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | 1.723B |
| October 31, 2023 | 1.701B |
| July 31, 2023 | 1.650B |
| April 30, 2023 | 1.618B |
| January 31, 2023 | 1.575B |
| October 31, 2022 | 1.560B |
| July 31, 2022 | 1.607B |
| April 30, 2022 | 1.632B |
| January 31, 2022 | 1.617B |
| October 31, 2021 | 1.644B |
| July 31, 2021 | 1.618B |
| April 30, 2021 | 1.581B |
| January 31, 2021 | 1.556B |
| October 31, 2020 | 1.515B |
| July 31, 2020 | 1.495B |
| April 30, 2020 | 1.517B |
| January 31, 2020 | 1.548B |
| October 31, 2019 | 1.532B |
| July 31, 2019 | 1.519B |
| April 30, 2019 | 1.498B |
| January 31, 2019 | 1.472B |
| October 31, 2018 | 1.437B |
| July 31, 2018 | 1.427B |
| April 30, 2018 | 1.397B |
| January 31, 2018 | 1.400B |
| Date | Value |
|---|---|
| October 31, 2017 | 1.360B |
| July 31, 2017 | 1.285B |
| April 30, 2017 | 1.219B |
| January 31, 2017 | 1.236B |
| October 31, 2016 | 1.240B |
| July 31, 2016 | 1.292B |
| April 30, 2016 | 1.334B |
| January 31, 2016 | 1.353B |
| October 31, 2015 | 1.387B |
| July 31, 2015 | 1.413B |
| April 30, 2015 | 1.425B |
| January 31, 2015 | 1.582B |
| October 31, 2014 | 1.616B |
| July 31, 2014 | 1.631B |
| April 30, 2014 | 1.642B |
| January 31, 2014 | 1.612B |
| October 31, 2013 | 1.616B |
| July 31, 2013 | 1.612B |
| April 30, 2013 | 1.564B |
| January 31, 2013 | 1.449B |
| October 31, 2012 | 1.457B |
| July 31, 2012 | 1.378B |
| April 30, 2012 | 1.362B |
| January 31, 2012 | 1.304B |
| October 31, 2011 | 1.197B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.495B
Minimum
Jul 2020
1.723B
Maximum
Jan 2024
1.590B
Average
1.581B
Median
Apr 2021
Revenue (TTM) Benchmarks
| Abliva AB | -- |
| Karolinska Development AB | 0.1834M |
| Calliditas Therapeutics AB | 135.65M |
| Oncopeptides AB | 2.890M |
| Olink Holding AB | 169.60M |